Laman UtamaAIMI • OTCMKTS
add
AIM ImmunoTech Inc
Tutup sebelumnya
$0.085
Julat hari
$0.079 - $0.090
Julat tahun
$0.025 - $0.12
Permodalan pasaran
6.13J USD
Bilangan Purata
300.82K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
OTCMKTS
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Hasil | 16.00K | -60.00% |
Perbelanjaan pengendalian | 3.62J | -37.13% |
Pendapatan bersih | -3.70J | 36.31% |
Margin untung bersih | -23.16K | -59.23% |
Pendapatan bagi setiap syer | -0.05 | 58.33% |
EBITDA | -3.56J | 37.26% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 2.25J | -79.46% |
Jumlah aset | 6.25J | -61.41% |
Jumlah liabiliti | 10.10J | -11.07% |
Jumlah ekuiti | -3.86J | — |
Syer tertunggak | 76.42J | — |
Harga kepada buku | -1.70 | — |
Pulangan pada aset | -121.80% | — |
Pulangan pada modal | -6,371.48% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -3.70J | 36.31% |
Tunai daripada operasi | -2.36J | 50.97% |
Tunai daripada pelaburan | 898.00K | 668.35% |
Tunai daripada pembiayaan | 660.00K | -76.67% |
Perubahan bersih dalam tunai | -803.00K | 62.55% |
Aliran tunai bebas | -1.82J | 34.19% |
Perihal
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Diasaskan
1966
Ibu pejabat
Tapak web
Pekerja
22